The Lilly drug company has stated that it has made grains containing Orforgloberon and taken orally once a day to reduce weight, the first of its kind. The people who took the medicine lost 7.5 kilograms in 9 months in an experiment it had.
These daily weight loss pills, which work like an Osmbeck injection to burn fat, may be available in the United Kingdom early next year, according to the British Daily Mail.
This pill is working by targeting the same GLP-1 receptors that you use weight loss injections such as Ozmbeak, Wigofi, and Mongaro, which works to curb appetite and make users feel full for a longer period.
Laila has not yet determined the cost of the drug, but its production and transportation is easier than injection, so it is likely to be a less expensive option. Pills can be stored at room temperature and eaten at any time of the day, with or without food.
The effectiveness of the new drug
559 people participated in the study, and aimed to measure the success of treatment in treating diabetes, and also studied its effect on weight loss.
All participants initially had a 23 or more body mass index, in addition to their type 2 diabetes.
Participants were given either a fictitious drug or one of the three potential doses of Orforgloberone, and those who took the highest dose of 7.2 kilograms, or 7.9% of their bodies, lost during the study period.
With the use of the medicine, some participants have witnessed a significant decrease in blood sugar to the extent that the disease entered the stage of inception. The threat in diabetes is to maintain blood sugar levels in the normal range for at least two months after you stop taking anti -diabetes medications.
It is worth noting that weight loss did not start stability, which means that the final results are likely to be more impressive.